Acrobiosystems for English
icon_bulk_orderAchat groupé/Commande rapide
user
  1. Tableau de bord
  2. Mon profil
  3. Mon adresse
  4. Mes commandes
  5. Adhésion à Acro
Connexion Inscription
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
Il n'y a pas de produit dans le panier !
Mon panier|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > TFPI-2

TFPI-2

Brief Information

Name:DNA-(apurinic or apyrimidinic site) lyase
Target Synonym:AP endonuclease 1,DNA-(apurinic or apyrimidinic site) lyase,APE1,APEN,REF-1,Apurinic-apyrimidinic endonuclease 1,APEX nuclease,REF1,APEX,APEX1,Apurinic/Apyrimidinic Endodeoxyribonuclease 1,APEX Nuclease (Multifunctional DNA Repair Enzyme) 1,Redox Factor-1,HAP1,APE,APX,APEX Nuclease (Multifunctional DNA Repair Enzyme),Deoxyribonuclease (Apurinic Or Apyrimidinic),Apurinic/Apyrimidinic (Abasic) Endonuclease,AP Endonuclease Class I,Protein REF-1,AP Lyase,APE-1,DNA-(apurinic or apyrimidinic site) end
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Product> Filter Results
Par statut du produit :
Par catégorie de produit :
Par espèce :
Par étiquette :
Par conjugaison :
Cat . Non Espèces Description du produit Structure Pureté Caractéristique
TF2-H5227 Human Human TFPI-2 Protein, His Tag
TF2-H5227-structure
TF2-H5227-sds
ACRO Quality

Synonym Name

TFPI2,PP5,REF1

Background

Tissue Factor Pathway Inhibitor 2 (TFPI­2) is also known as placental protein 5 (PP5) and retinal pigment epithelial cell factor 1 (REF­1), is a member of the Kunitz-type serine proteinase inhibitor family, is a structural homologue of tissue factor pathway inhibitor (TFPI). TFPI2 is highly abundant in the full-term placenta and widely expressed in umbilical vein endothelial cells, liver, placenta, heart, pancreas, and maternal serum at advanced pregnancy. TFPI­2 may play a role in the regulation of plasmin-mediated matrix remodeling. Inhibits trypsin, plasmin, factor VIIa/tissue factor and weakly factor Xa and has no effect on thrombin. Reduced synthesis of TFPI-2 has been related to numerous pathophysiological processes such as inflammation, angiogenesis, atherosclerosis, retinal degeneration and tumor growth / metastasis.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
APX-3330 E-3330; APX-3330 Phase 2 Clinical Eisai Co Ltd Neoplasms; Diabetic macular oedema; Diabetic Retinopathy Details
APX-3330 E-3330; APX-3330 Phase 2 Clinical Eisai Co Ltd Neoplasms; Diabetic macular oedema; Diabetic Retinopathy Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
E-Mail
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Laisser un message

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap